281 related articles for article (PubMed ID: 33224469)
1. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms.
Marcatili M; Sala C; Dakanalis A; Colmegna F; D'Agostino A; Gambini O; Dell'Osso B; Benatti B; Conti L; Clerici M
Ther Adv Psychopharmacol; 2020; 10():2045125320968331. PubMed ID: 33224469
[TBL] [Abstract][Full Text] [Related]
2. [Ketamine's fast-acting antidepressant mechanisms: state of the art and new research perspectives].
Marcatili M; Stefana A; Sala C; Conti L; Colmegna F; Clerici M; Dakanalis A
Riv Psichiatr; 2022; 57(2):57-66. PubMed ID: 35426424
[TBL] [Abstract][Full Text] [Related]
3. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
4. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
5. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
[TBL] [Abstract][Full Text] [Related]
6. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.
Iadarola ND; Niciu MJ; Richards EM; Vande Voort JL; Ballard ED; Lundin NB; Nugent AC; Machado-Vieira R; Zarate CA
Ther Adv Chronic Dis; 2015 May; 6(3):97-114. PubMed ID: 25954495
[TBL] [Abstract][Full Text] [Related]
7. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
Niciu MJ; Henter ID; Luckenbaugh DA; Zarate CA; Charney DS
Annu Rev Pharmacol Toxicol; 2014; 54():119-39. PubMed ID: 24392693
[TBL] [Abstract][Full Text] [Related]
8. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
9. Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.
Réus GZ; de Moura AB; Borba LA; Abelaira HM; Quevedo J
Mol Neuropsychiatry; 2019 Oct; 5(4):178-189. PubMed ID: 31768371
[TBL] [Abstract][Full Text] [Related]
10. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.
Browne CA; Lucki I
Front Pharmacol; 2013 Dec; 4():161. PubMed ID: 24409146
[TBL] [Abstract][Full Text] [Related]
15. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
Hashimoto K
Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
[TBL] [Abstract][Full Text] [Related]
16. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto K
Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
[TBL] [Abstract][Full Text] [Related]
17. Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?
Quintanilla B; Zarate CA; Pillai A
Mol Psychiatry; 2024 Apr; ():. PubMed ID: 38575806
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
Aleksandrova LR; Phillips AG; Wang YT
J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
[TBL] [Abstract][Full Text] [Related]
19. Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action.
Aleksandrova LR; Wang YT; Phillips AG
Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 30556028
[TBL] [Abstract][Full Text] [Related]
20. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
